Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00058799
Status:
COMPLETED
Last Update Posted:
2020-01-21
First Post:
2003-04-11
Brief Title:
Treating High Risk Leukemia With CD40 Ligand IL-2 Gene Modified Tumor Vaccine
Sponsor:
Baylor College of Medicine
Organization:
Baylor College of Medicine
Organization Data
Organization:
Baylor College of Medicine
Class:
OTHER
Study ID:
H6408-Leu Leu
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Baylor College of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
Malcolm Brenner
Responsible Party Title:
Dist Serv Prof Center for Gene Therapy
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Baylor College of Medicine
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Center for Cell and Gene Therapy Baylor College of Medicine | OTHER |
| The Methodist Hospital Research Institute | OTHER |